If you’ve ever been prescribed an expensive new medication, you may be familiar with step therapy. Rather than pay for a costly new drug, many insurance companies require patients to try cheaper alternatives first. As drug prices have skyrocketed in recent years, step therapy has become increasingly common, but now, legislatures in many states are pushing back. Heartland Health Monitor’s Alex Smith has the story.
Heartland Health Monitor is a regional reporting collaboration focusing on health issues in Missouri and Kansas.